Company: STAA
Filing Date: 2025-12-10
Form Type: DEFA14A
Source: 0001193125-25-313008
Chunk: 1

Company: STAAR SURGICAL CO
Filing Date: 2025-12-10
Form: DEFA14A
Chunk 1
---
 other shareholder objections, including management compensation. Among other things, the amendment modifies the approach to RSUs and PSUs, which is
discussed in the updated FAQ regarding employee compensation and benefits (link).

The amendment announced today does not change the timing of the Special
Meeting of Stockholders, which is scheduled for Friday, December 19. The record date for the Special Meeting remains the close of business on October 24, 2025. Stockholders who hold shares as of the record date will be eligible to vote at the
Special Meeting on December 19, 2025.

I am proud of each of you, as you have done a great job of staying focused on the business despite the noise
that has surrounded STAAR in the last several months. You have continued to advance the business, improve our operations and deliver against objectives and I am very grateful for your contributions.

There are no changes to our go forward approach as a result of this new amendment to the merger agreement. Prior to the closing of the merger, we will
continue to operate business as usual. As we have discussed in the past, I would ask for you to help by remaining focused on your responsibilities to advance the important work underway across the Company to impact as many customers and patients as
possible.

On behalf of the STAAR Board of Directors and management team, thank you for your continued dedication to STAAR and our mission. We have much
to be thankful for, and I wish you and your families a happy and healthy holiday season.

Sincerely,

Stephen C. Farrell

Chief Executive Officer

Also on December 9, 2025, the Company updated its Employee Q&A regarding compensation and benefits to STAAR employees with the following new and updated FAQs:

| • |     | Upon the closing of the merger, your shares of STAAR common stock will convert into the right to receive $30.75 
 per share in cash, without interest.                                                                            |

| • |     | Promptly following the closing of the merger, you will receive instructions as to how to surrender your shares of  
 STAAR common stock to STAAR’s exchange agent, which will be responsible for making payments to STAAR shareholders. |

| • |     | In-the-money options: Upon                                                                                                                                                                                                                                                                                                                                                                 
 the closing of the merger, any unvested options will automatically vest and you will become entitled to a cash payment for each share underlying your unvested options and vested options that you have not exercised that are “in-the-money options” (i.e